Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes*
David Frescas,
Luca Valenti, , and
Domenico Accili
Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, New York 10032
Abstract:
Activation of NAD-dependent deacetylases, or Sirtuins, prolongslife span and mimics the effects of caloric restriction in yeast.The FoxO subfamily of forkhead transcription factors has beenshown to mediate some of the effects of Sirtuins. Here we haveshown that Sirtuin activation or hydrogen peroxide treatmentoverrides the phosphorylation-dependent nuclear exclusion ofFoxO1 caused by growth factors and causes nuclear translocationof FoxO1 in hepatocytes. Kinetic measurements of nuclear fluorescencerecovery after photobleaching show that FoxO1 is readily diffusiblewithin the nucleus under normal conditions but becomes restrictedwithin a nuclear subdomain following treatment with the prototypicalSirtuin agonist resveratrol or oxidative stress. Expressionof FoxO1 target genes is accordingly increased, leading to activationof gluconeogenesis and increased glucose release from hepatocytes.Selective modulation of the FoxO/Sirtuin interaction representsa promising therapeutic modality for metabolic disorders.
Received for publication November 1, 2004.
Revision received March 18, 2005.
* This work was supported by National Institutes of Health GrantsDK57539 and DK63608 (Columbia Diabetes and Endocrinology ResearchCenter). The costs of publication of this article were defrayedin part by the payment of page charges. This article must thereforebe hereby marked "advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
To whom correspondence should be addressed: 1150 St. Nicholas Ave., New York, NY 10032. Tel.: 212-851-5332; Fax: 212-851-5331; E-mail: da230{at}columbia.edu.
The editors suggest the following Related Resources on Science sites:
F. Seiler, J. Hellberg, P. M. Lepper, A. Kamyschnikow, C. Herr, M. Bischoff, F. Langer, H.-J. Schafers, F. Lammert, M. D. Menger, et al. (2013)
J. Immunol.
190, 1603-1613
|Abstract »|Full Text »|PDF »
Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.
H. Li, M. Xu, J. Lee, C. He, and Z. Xie (2012)
Am J Physiol Endocrinol Metab
303, E1234-E1244
|Abstract »|Full Text »|PDF »
Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism.
R. Nogueiras, K. M. Habegger, N. Chaudhary, B. Finan, A. S. Banks, M. O. Dietrich, T. L. Horvath, D. A. Sinclair, P. T. Pfluger, and M. H. Tschop (2012)
Physiol Rev
92, 1479-1514
|Abstract »|Full Text »|PDF »
Increased Atherosclerosis and Endothelial Dysfunction in Mice Bearing Constitutively Deacetylated Alleles of Foxo1 Gene.
L. Qiang, K. Tsuchiya, J.-Y. Kim-Muller, H. V. Lin, C. Welch, and D. Accili (2012)
J. Biol. Chem.
287, 13944-13951
|Abstract »|Full Text »|PDF »
Necdin Controls Foxo1 Acetylation in Hypothalamic Arcuate Neurons to Modulate the Thyroid Axis.
K. Hasegawa, T. Kawahara, K. Fujiwara, M. Shimpuku, T. Sasaki, T. Kitamura, and K. Yoshikawa (2012)
J. Neurosci.
32, 5562-5572
|Abstract »|Full Text »|PDF »
Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer.
Apo-10'-Lycopenoic Acid, a Lycopene Metabolite, Increases Sirtuin 1 mRNA and Protein Levels and Decreases Hepatic Fat Accumulation in ob/ob Mice.
J. Chung, K. Koo, F. Lian, K. Q. Hu, H. Ernst, and X.-D. Wang (2012)
J. Nutr.
142, 405-410
|Abstract »|Full Text »|PDF »
Interferon gamma (IFN-{gamma}) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription.
P. Li, Y. Zhao, X. Wu, M. Xia, M. Fang, Y. Iwasaki, J. Sha, Q. Chen, Y. Xu, and A. Shen (2012)
Nucleic Acids Res.
40, 1609-1620
|Abstract »|Full Text »|PDF »
Posttranslational modifications control FoxO3 activity during denervation.
E. Bertaggia, L. Coletto, and M. Sandri (2012)
Am J Physiol Cell Physiol
302, C587-C596
|Abstract »|Full Text »|PDF »
Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin.
K.-K. Ho, V. A. McGuire, C.-Y. Koo, K. W. Muir, N. de Olano, E. Maifoshie, D. J. Kelly, U. B. McGovern, L. J. Monteiro, A. R. Gomes, et al. (2012)
J. Biol. Chem.
287, 1545-1555
|Abstract »|Full Text »|PDF »
Glucagon-Like Peptide 1 Inhibits the Sirtuin Deacetylase SirT1 to Stimulate Pancreatic {beta}-Cell Mass Expansion.
P.-O. Bastien-Dionne, L. Valenti, N. Kon, W. Gu, and J. Buteau (2011)
Diabetes
60, 3217-3222
|Abstract »|Full Text »|PDF »
NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II.
I. Diebold, A. Petry, M. Burger, J. Hess, and A. Gorlach (2011)
Mol. Biol. Cell
22, 4424-4434
|Abstract »|Full Text »|PDF »
Molecular Inflammation as an Underlying Mechanism of the Aging Process and Age-related Diseases.
H. Y. Chung, E. K. Lee, Y. J. Choi, J. M. Kim, D. H. Kim, Y. Zou, C. H. Kim, J. Lee, H. S. Kim, N. D. Kim, et al. (2011)
Journal of Dental Research
90, 830-840
|Abstract »|PDF »
p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle.
S. M. Senf, P. B. Sandesara, S. A. Reed, and A. R. Judge (2011)
Am J Physiol Cell Physiol
300, C1490-C1501
|Abstract »|Full Text »|PDF »
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.
A. Davalos, L. Goedeke, P. Smibert, C. M. Ramirez, N. P. Warrier, U. Andreo, D. Cirera-Salinas, K. Rayner, U. Suresh, J. C. Pastor-Pareja, et al. (2011)
PNAS
108, 9232-9237
|Abstract »|Full Text »|PDF »
Involvement of Oxygen-regulated Protein 150 in AMP-activated Protein Kinase-mediated Alleviation of Lipid-induced Endoplasmic Reticulum Stress.
Y. Wang, Z. Wu, D. Li, D. Wang, X. Wang, X. Feng, and M. Xia (2011)
J. Biol. Chem.
286, 11119-11131
|Abstract »|Full Text »|PDF »
Pancreatic Tumor Suppression by Benzyl Isothiocyanate Is Associated with Inhibition of PI3K/AKT/FOXO Pathway.
S. R. Boreddy, K. C. Pramanik, and S. K. Srivastava (2011)
Clin. Cancer Res.
17, 1784-1795
|Abstract »|Full Text »|PDF »
FoxO1 and SIRT1 Regulate {beta}-Cell Responses to Nitric Oxide.
K. J. Hughes, G. P. Meares, P. A. Hansen, and J. A. Corbett (2011)
J. Biol. Chem.
286, 8338-8348
|Abstract »|Full Text »|PDF »
Acetylation-Deacetylation of the Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-related Factor 2) Regulates Its Transcriptional Activity and Nucleocytoplasmic Localization.
Y. Kawai, L. Garduno, M. Theodore, J. Yang, and I. J. Arinze (2011)
J. Biol. Chem.
286, 7629-7640
|Abstract »|Full Text »|PDF »
Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism.
P. W. Caton, N. K. Nayuni, N. Q. Khan, E. G. Wood, and R. Corder (2011)
J. Endocrinol.
208, 273-283
|Abstract »|Full Text »|PDF »
Fine-tuned regulation of the PGC-1{alpha} gene transcription by different intracellular signaling pathways.
T. Hong, J. Ning, X. Yang, H.-Y. Liu, J. Han, Z. Liu, and W. Cao (2011)
Am J Physiol Endocrinol Metab
300, E500-E507
|Abstract »|Full Text »|PDF »
Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.
D. Wei, R. Tao, Y. Zhang, M. F. White, and X. C. Dong (2011)
Am J Physiol Endocrinol Metab
300, E312-E320
|Abstract »|Full Text »|PDF »
SIRT1 Is a Novel Regulator of Key Pathways of Human Labor.
M. Lappas, A. Mitton, R. Lim, G. Barker, C. Riley, and M. Permezel (2011)
Biol Reprod
84, 167-178
|Abstract »|Full Text »|PDF »
Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box-Binding Protein 1, and E-Cadherin Regulation.
M. Shiota, Y. Song, A. Yokomizo, K. Kiyoshima, Y. Tada, H. Uchino, T. Uchiumi, J. Inokuchi, Y. Oda, K. Kuroiwa, et al. (2010)
Clin. Cancer Res.
16, 5654-5663
|Abstract »|Full Text »|PDF »
The Forkhead Transcription Factor Hcm1 Promotes Mitochondrial Biogenesis and Stress Resistance in Yeast.
M. J. Rodriguez-Colman, G. Reverter-Branchat, M. A. Sorolla, J. Tamarit, J. Ros, and E. Cabiscol (2010)
J. Biol. Chem.
285, 37092-37101
|Abstract »|Full Text »|PDF »
Survival strategies of a sterol auxotroph.
M. Carvalho, D. Schwudke, J. L. Sampaio, W. Palm, I. Riezman, G. Dey, G. D. Gupta, S. Mayor, H. Riezman, A. Shevchenko, et al. (2010)
Development
137, 3675-3685
|Abstract »|Full Text »|PDF »
Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1.
W. K. Oh, K. B. Cho, T. T. Hien, T. H. Kim, H. S. Kim, T. T. Dao, H.-K. Han, S.-M. Kwon, S.-G. Ahn, J.-H. Yoon, et al. (2010)
Mol. Pharmacol.
78, 855-864
|Abstract »|Full Text »|PDF »
The DNA damage repair protein Ku70 interacts with FOXO4 to coordinate a conserved cellular stress response.
A. B. Brenkman, N. J. F. van den Broek, P. L. J. de Keizer, D. C. van Gent, and B. M. T. Burgering (2010)
FASEB J
24, 4271-4280
|Abstract »|Full Text »|PDF »
Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia.
R. A. Haeusler, S. Han, and D. Accili (2010)
J. Biol. Chem.
285, 26861-26868
|Abstract »|Full Text »|PDF »
Uncoupling of Acetylation from Phosphorylation Regulates FoxO1 Function Independent of Its Subcellular Localization.
L. Qiang, A. S. Banks, and D. Accili (2010)
J. Biol. Chem.
285, 27396-27401
|Abstract »|Full Text »|PDF »
T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate Gluconeogenesis.
A. Fukushima, K. Loh, S. Galic, B. Fam, B. Shields, F. Wiede, M. L. Tremblay, M. J. Watt, S. Andrikopoulos, and T. Tiganis (2010)
Diabetes
59, 1906-1914
|Abstract »|Full Text »|PDF »
The Increase in Cardiac Pyruvate Dehydrogenase Kinase-4 after Short-Term Dexamethasone Is Controlled by an Akt-p38-Forkhead Box Other Factor-1 Signaling Axis.
P. Puthanveetil, Y. Wang, F. Wang, M. S. Kim, A. Abrahani, and B. Rodrigues (2010)
Endocrinology
151, 2306-2318
|Abstract »|Full Text »|PDF »
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
P. W Caton, N. K Nayuni, J. Kieswich, N. Q Khan, M. M Yaqoob, and R. Corder (2010)
J. Endocrinol.
205, 97-106
|Abstract »|Full Text »|PDF »
PPAR control: it's SIRTainly as easy as PGC.
M. C Sugden, P. W Caton, and M. J Holness (2010)
J. Endocrinol.
204, 93-104
|Abstract »|Full Text »|PDF »
SIRT1 Genetic Variation Is Related to BMI and Risk of Obesity.
M.C. Zillikens, J. B.J. van Meurs, F. Rivadeneira, N. Amin, A. Hofman, B. A. Oostra, E. J.G. Sijbrands, J. C.M. Witteman, H. A.P. Pols, C. M. van Duijn, et al. (2009)
Diabetes
58, 2828-2834
|Abstract »|Full Text »|PDF »
FoxO1 and HNF-4 Are Involved in Regulation of Hepatic Glucokinase Gene Expression by Resveratrol.
G. K. Ganjam, E. Y. Dimova, T. G. Unterman, and T. Kietzmann (2009)
J. Biol. Chem.
284, 30783-30797
|Abstract »|Full Text »|PDF »
Activation of SIRT1 by Resveratrol Represses Transcription of the Gene for the Cytosolic Form of Phosphoenolpyruvate Carboxykinase (GTP) by Deacetylating Hepatic Nuclear Factor 4{alpha}.
J. Yang, X. Kong, M. E. S. Martins-Santos, G. Aleman, E. Chaco, G. E. Liu, S.-Y. Wu, D. Samols, P. Hakimi, C.-M. Chiang, et al. (2009)
J. Biol. Chem.
284, 27042-27053
|Abstract »|Full Text »|PDF »
Adiponectin: A Key Adipokine in Alcoholic Fatty Liver.
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
D. M. Erion, S. Yonemitsu, Y. Nie, Y. Nagai, M. P. Gillum, J. J. Hsiao, T. Iwasaki, R. Stark, D. Weismann, X. X. Yu, et al. (2009)
PNAS
106, 11288-11293
|Abstract »|Full Text »|PDF »
MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation.
W. Fu, Q. Ma, L. Chen, P. Li, M. Zhang, S. Ramamoorthy, Z. Nawaz, T. Shimojima, H. Wang, Y. Yang, et al. (2009)
J. Biol. Chem.
284, 13987-14000
|Abstract »|Full Text »|PDF »
Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer: A TARGET FOR PROSTATE CANCER MANAGEMENT VIA ITS INHIBITION?.
B. Jung-Hynes, M. Nihal, W. Zhong, and N. Ahmad (2009)
J. Biol. Chem.
284, 3823-3832
|Abstract »|Full Text »|PDF »
Monitoring FoxO1 Localization in Chemically Identified Neurons.
M. Fukuda, J. E. Jones, D. Olson, J. Hill, C. E. Lee, L. Gautron, M. Choi, J. M. Zigman, B. B. Lowell, and J. K. Elmquist (2008)
J. Neurosci.
28, 13640-13648
|Abstract »|Full Text »|PDF »
Forkhead box-O transcription factor: critical conductors of cancer's fate.
C. Weidinger, K. Krause, A. Klagge, S. Karger, and D. Fuhrer (2008)
Endocr. Relat. Cancer
15, 917-929
|Abstract »|Full Text »|PDF »
Inhibition of Gluconeogenesis in Primary Hepatocytes by Stromal Cell-derived Factor-1 (SDF-1) through a c-Src/Akt-dependent Signaling Pathway.
H.-Y. Liu, G.-B. Wen, J. Han, T. Hong, D. Zhuo, Z. Liu, and W. Cao (2008)
J. Biol. Chem.
283, 30642-30649
|Abstract »|Full Text »|PDF »
The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression.
R. C.-Y. Hui, A. R. Gomes, D. Constantinidou, J. R. Costa, C. T. Karadedou, S. Fernandez de Mattos, M. P. Wymann, J. J. Brosens, A. Schulze, and E. W.-F. Lam (2008)
Mol. Cell. Biol.
28, 5886-5898
|Abstract »|Full Text »|PDF »
Resveratrol alleviates alcoholic fatty liver in mice.
J. M. Ajmo, X. Liang, C. Q. Rogers, B. Pennock, and M. You (2008)
Am J Physiol Gastrointest Liver Physiol
295, G833-G842
|Abstract »|Full Text »|PDF »
Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice.
A. G. Gomez-Valades, A. Mendez-Lucas, A. Vidal-Alabro, F. X. Blasco, M. Chillon, R. Bartrons, J. Bermudez, and J. C. Perales (2008)
Diabetes
57, 2199-2210
|Abstract »|Full Text »|PDF »
Suppression of Hepatic Glucose Production by Human Neutrophil {alpha}-Defensins through a Signaling Pathway Distinct from Insulin.
H.-Y. Liu, Q. F. Collins, F. Moukdar, D. Zhuo, J. Han, T. Hong, S. Collins, and W. Cao (2008)
J. Biol. Chem.
283, 12056-12063
|Abstract »|Full Text »|PDF »
Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis.
L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A. Ludovica Fracanzani, M. Zappa, E. Lattuada, G. Roviaro, and S. Fargion (2008)
Diabetes
57, 1355-1362
|Abstract »|Full Text »|PDF »
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
E. L. Greer and A. Brunet (2008)
J. Cell Sci.
121, 407-412
|Full Text »|PDF »
Forkhead Transcription Factors Coordinate Expression of Myocardial KATP Channel Subunits and Energy Metabolism.
P. Philip-Couderc, N. I. Tavares, A. Roatti, R. Lerch, C. Montessuit, and A. J. Baertschi (2008)
Circ. Res.
102, e20-e35
|Abstract »|Full Text »|PDF »
FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases.
Y. G. Ni, N. Wang, D. J. Cao, N. Sachan, D. J. Morris, R. D. Gerard, M. Kuro-o, B. A. Rothermel, and J. A. Hill (2007)
PNAS
104, 20517-20522
|Abstract »|Full Text »|PDF »
SIRT1 controls endothelial angiogenic functions during vascular growth.
M. Potente, L. Ghaeni, D. Baldessari, R. Mostoslavsky, L. Rossig, F. Dequiedt, J. Haendeler, M. Mione, E. Dejana, F. W. Alt, et al. (2007)
Genes & Dev.
21, 2644-2658
|Abstract »|Full Text »|PDF »
Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) Binding and the Inhibition of Basal Glucose-6-Phosphatase Catalytic Subunit Gene Transcription by Insulin.
H. Onuma, B. T. Vander Kooi, J. N. Boustead, J. K. Oeser, and R. M. O'Brien (2006)
Mol. Endocrinol.
20, 2831-2847
|Abstract »|Full Text »|PDF »
Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction..
The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular Translocation.
D. Kawamori, H. Kaneto, Y. Nakatani, T.-a. Matsuoka, M. Matsuhisa, M. Hori, and Y. Yamasaki (2006)
J. Biol. Chem.
281, 1091-1098
|Abstract »|Full Text »|PDF »
Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation.
H. Matsuzaki, H. Daitoku, M. Hatta, H. Aoyama, K. Yoshimochi, and A. Fukamizu (2005)
PNAS
102, 11278-11283
|Abstract »|Full Text »|PDF »